Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1
    Finance

    Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1

    Published by Global Banking & Finance Review®

    Posted on July 8, 2025

    1 min read

    Last updated: January 23, 2026

    Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1 - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:GDPfinancial marketseconomic growthforeign exchangeinvestment

    Quick Summary

    Ireland's Q1 GDP growth was revised to 7.4%, driven by pharmaceutical exports. MDD rose to 2.0%, indicating domestic economic strength.

    Ireland's Q1 GDP Growth Adjusted Down to 7.4% Amid Pharma Surge

    DUBLIN (Reuters) -Rapid growth in Ireland's gross domestic product (GDP) during the first three months of the year was revised down on Tuesday to 7.4% quarter-on-quarter from 9.7% previously.

    The growth was driven by a surge in pharmaceutical exports to the U.S. ahead of threatened tariffs, officials have said.

    With Ireland's large multinational sector often distorting GDP, officials prefer to use modified domestic demand (MDD) to gauge the strength of the domestic economy.

    Quarter-on-quarter MDD growth was revised sharply up to 2.0% from a provisional 0.8%, Central Statistics Office (CSO) data showed.

    Revisions to previous quarters meant MDD grew by a slower 1.8% in 2024 compared to the 2.7% initially reported.

    GDP, which is still used to calculate Ireland's share of activity across the euro zone, grew by 2.6% in 2024 versus an initial estimate of +1.2%.

    Modified gross national income (GNI*), an annual measure that also strips out the distorting impacts of multinationals to give a more accurate picture of the total size of the Irish economy, suggested it grew by 4.8% in 2024 compared to 2023.

    (Reporting by Padraic Halpin; Editing by Conor Humphries)

    Key Takeaways

    • •Ireland's Q1 GDP growth revised to 7.4% from 9.7%.
    • •Pharmaceutical exports to the U.S. drove the growth.
    • •Modified domestic demand increased to 2.0%.
    • •GDP growth in 2024 was 2.6%, revised from 1.2%.
    • •Modified GNI* grew by 4.8% in 2024.

    Frequently Asked Questions about Pharma-driven Irish GDP growth revised down to 7.4% q/q in Q1

    1What was the revised GDP growth for Ireland in Q1?

    Ireland's GDP growth for the first quarter was revised down to 7.4% quarter-on-quarter from a previous estimate of 9.7%.

    2What drove the growth in Ireland's GDP?

    The growth was primarily driven by a surge in pharmaceutical exports to the U.S. ahead of threatened tariffs.

    3What is modified domestic demand (MDD)?

    Modified domestic demand (MDD) is a metric preferred by officials to gauge the strength of the domestic economy, as it accounts for distortions from the large multinational sector.

    4How did MDD growth change in the latest revision?

    The quarter-on-quarter MDD growth was revised sharply up to 2.0% from a provisional estimate of 0.8%.

    5What does modified gross national income (GNI*) indicate?

    Modified gross national income (GNI*) is an annual measure that strips out the distorting impacts of multinationals to provide a more accurate picture of the total size of the Irish economy.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostFTSE 100 closes at three-week high as investors monitor US trade talks
    Next Finance PostMonzo fined $28 million by UK regulator for inadequate financial crime controls